Related Experiment Video
Updated: Mar 7, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1
Background/Aims:
Transforming growth factor beta 1 (TGF-β1) plays a critical role in the pathogenesis of glomerulosclerosis. The purpose of this study was to examine the effects of inhibition of transient receptor potential cation channel C6 (TRPC6) on podocyte injury induced by TGF-β1 via nephrin and desmin mechanisms.
Methods:
A rat model of nephropathy was first induced by intravenous injections of adriamycin to determine TRPC6 signal pathway engaged in glomerulosclerosis in vivo. Conditionally immortalized podocytes were cultured in vitro and they were divided into four groups: control; TGF-β1 treatment; TGF-β1 with TRPC6 knockdown and TGF-β1 without TRPC6 knockdown. Real time RT-PCR and Western blot analysis were employed to determine the mRNA and protein of expression of nephrin, desmin and caspase-9, respectively. Flow cytometry was used to examine the apoptotic rate of podocytes and DAPI fluorescent staining was used to determine apoptotic morphology.
Results:
In vivo experiment, adriamycin significantly upregulated the protein expression of TGF-β1, TRPC6, desmin and caspase-9, and decreased nephrin. Consistent with the latter results, in vitro experiment mRNA and protein expression of desmin and caspase-9 was increased in cultured TGF-β1-treated podocytes, whereas nephrin was declined as compared with the control group. Importantly, TRPC6 knockdown significantly attenuated the upregulated desmin and caspase-9, and alleviated impairment of nephrin induced by TGF-β1. Moreover, typical morphologic features were presented in apoptotic podocytes. The number of apoptotic podocytes was increased after exposure to TGF-β1 and this was alleviated after TRPC6 knockdown. TRPC6 knockdown also decreased an apoptosis rate of TGF-β1-treated podocytes. Note that negative TRPC6 transfection control failed to alter an increase of the apoptosis rate in TGF-β1-treated podocytes.
Conclusions:
TGF-β1 induced by glomerulosclerosis impairs the protein expression of nephrin and amplifies the protein expression of desmin and caspase -9 via TRPC6 signal pathway. Inhibition of TRPC6 alleviates these changes in podocytes-treated with TGF-β1 and attenuated apoptosis of podocytes. Our data suggest that TRPC6 signal plays an important role in mediating TGF-β1-induced podocyte injury via nephrin, desmin and caspase-9. Results of the current study also indicate that blocking TRPC6 signal pathway has a protective effect on podocyte injury. Targeting one or more of these signaling molecules may present new opportunities for treatment and management of podocyte injury observed in glomerulosclerosis.
Insights
Inhibiting transient receptor potential cation channel C6 (TRPC6) protects podocytes from transforming growth factor beta 1 (TGF-β1)-induced injury. Blocking TRPC6 reduces apoptosis and preserves nephrin expression, offering a potential therapeutic strategy for glomerulosclerosis.
Area of Science:
- Nephrology
- Cell Biology
- Molecular Biology
Background:
- Transforming growth factor beta 1 (TGF-β1) is implicated in glomerulosclerosis pathogenesis.
- Podocyte injury is a key feature of glomerulosclerosis.
Purpose of the Study:
- To investigate the role of transient receptor potential cation channel C6 (TRPC6) in TGF-β1-induced podocyte injury.
- To examine the effects of TRPC6 inhibition on nephrin and desmin expression in podocytes.
Main Methods:
- Adriamycin-induced nephropathy in rats to model glomerulosclerosis in vivo.
- In vitro culture of podocytes treated with TGF-β1 and TRPC6 knockdown.
- Real-time RT-PCR and Western blot to assess gene and protein expression (nephrin, desmin, caspase-9).
- Flow cytometry and DAPI staining to evaluate podocyte apoptosis.
Main Results:
- TGF-β1 upregulated TGF-β1, TRPC6, desmin, and caspase-9, while decreasing nephrin in vivo and in vitro.
- TRPC6 knockdown attenuated TGF-β1-induced increases in desmin and caspase-9 and protected nephrin.
- TRPC6 inhibition significantly reduced podocyte apoptosis rates and morphological signs of cell death.
Conclusions:
- TGF-β1 induces glomerulosclerosis by altering nephrin, desmin, and caspase-9 expression via the TRPC6 pathway.
- Inhibiting TRPC6 demonstrates a protective effect against TGF-β1-induced podocyte injury.
- Targeting the TRPC6 signaling pathway offers a potential therapeutic avenue for glomerulosclerosis treatment.
Related Concept Videos
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
GPCR Desensitization

